Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Synergy CHC Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2012
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2024
FY2024
FY2025
Revenue
0.01
13.5
34.8
35.6
33.8
29.4
42.8
34.8
30.4
Cost of revenue
0.01
5.31
10.2
9.82
11
9.14
10.7
11.2
10.1
Gross profit
0
8.15
24.6
25.8
22.8
20.2
32.1
23.6
20.3
Selling and marketing
3.69
10.3
14
17.7
11.5
15.2
13
13.1
General and administrative
0.02
0.96
3.37
8.02
8.42
7.19
5.49
6.05
4.72
8.83
Operating expenses
0.02
0.96
7.66
21.7
24
27.7
28.2
21.3
17.8
28.8
Operating income
-0.96
0.49
2.93
1.82
-4.92
-7.96
10.8
5.8
-8.46
Interest expense
0
0
-0.96
-1.57
1.04
1.13
1.69
1.55
5.92
Interest income
-0
-0.01
0
0
0
0
0
0.02
Other non-operating income
0
7.63
2.79
1.01
1.49
1.12
-4.23
-3.57
-3.76
Pre-tax income
-0.96
-7.15
0.15
0.82
-6.41
-9.08
6.57
2.23
-12.2
Income tax
0
0
0.39
0.94
0.32
0.25
-0.13
0.23
0.1
0.12
Net income
-0.02
-0.96
-7.54
-0.8
0.5
-6.16
-9.21
6.34
2.12
-12.3
EBITDA
-0.96
1.09
4.1
3.32
-3.1
-6.74
10.8
5.93
-8.33
EPS, basic
0.00
-0.01
-0.11
-0.01
0.01
-0.07
-0.10
0.86
0.28
-1.27
EPS, diluted
0.00
-0.01
-0.11
-0.01
0.01
-0.07
-0.10
0.86
0.28
-1.27
Shares, basic (weighted)
153
97.2
68.9
81.7
89.2
89.9
89.9
7.37
7.59
9.72
Shares, diluted (weighted)
5.1
97.2
68.9
81.7
89.2
89.9
89.9
7.37
7.63
9.72
Balance sheet
FY2012
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2024
FY2024
FY2025
Cash and equivalents
0.03
0
3.64
2.52
1.96
0.46
1.22
0.63
0.69
2.62
Receivables
0
3.98
2.2
4.33
4.46
1.42
2.11
5.32
3.2
Inventory
0.03
0.69
1.1
2.84
2.67
1.86
3.73
1.72
3.74
Other current assets
0.01
0.42
1.35
1.14
0.83
0.19
0.8
1.86
0.35
Total current assets
0.03
0.06
9.34
7.26
10.4
8.94
5.05
11.8
16.1
10
Property, plant and equipment
0.01
0.26
0.29
0.27
0.14
Goodwill
11.5
7.79
7.79
7.79
Intangible assets
5.92
5.15
5.53
3.01
0.01
0.42
0.28
0.15
Total assets
0.03
0.06
26.8
20.5
24
20
5.19
12.2
16.3
10.2
Accounts payable
0.02
0.07
5.03
4.56
4.33
8.4
4.67
11.7
5.19
6.39
Accrued liabilities
0.01
0.13
0.28
0.3
0.22
0.11
Deferred revenue
0.04
0
0.05
0.01
0.01
0.02
0
Short-term debt
0.01
0.75
0.75
0
0.03
5.47
2.09
4
0.1
Total current liabilities
0.02
0.18
15.4
12.2
7.14
10.4
10.1
14
17.2
8.24
Long-term debt
0.75
13.1
7.46
25.1
Lease liabilities
8.33
Total liabilities
0.02
0.18
21.3
13.4
14.6
16
10.4
39.5
33
33.3
Total debt
0.01
0.75
0.75
5.47
15.2
11.5
25.1
Paid-in capital
0.06
0.87
13.9
16.4
18.4
18.8
19
19.1
8.4
33.6
Retained earnings
-0.05
-1.03
-8.57
-9.37
-8.87
-15
-24.2
-46.2
-44.1
-56.4
Treasury stock
-0.13
-0.13
-0.13
Other comprehensive income
0.02
-0.08
0.18
0.01
-0.1
-0.05
-0.15
Shareholders' equity
0.01
-0.13
5.42
7.11
9.43
3.97
-5.2
-27.3
-16.6
-23.1
Total equity
0.01
-0.13
5.42
7.11
9.43
3.97
-5.2
-27.3
-16.6
-23.1
Total liabilities and equity
0.03
0.06
26.8
20.5
24
20
5.19
12.2
16.3
10.2
Shares outstanding
180
62.1
81.7
88.8
89.9
89.9
89.9
7.37
8.54
11.3
Cash flow statement
FY2012
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2024
FY2024
FY2025
Net income
-0.02
-0.96
-7.54
-0.8
0.5
-6.16
-9.21
6.34
2.12
-12.3
Depreciation and amortization
0
0.61
1.17
1.49
1.82
1.21
0.03
0.13
0.13
Stock-based compensation
0.32
0.55
2.2
1.46
0.44
0.2
0
0
0.14
Change in receivables
-0
-1.32
1.73
-2.09
-0.19
3.03
1.38
-3.21
1.51
Change in inventory
-0.03
-0.02
-0.55
-1.45
-0.88
0.55
3.99
1.88
-2.92
Change in payables
0.06
0.48
-0.44
-1.29
2.39
-2.91
-6.65
-2.87
0.62
Cash from operations
-0.02
-0.49
-0.64
6.04
-0.83
1.3
2.95
0.42
-4.8
-2.59
Capital expenditures
-0.01
-0.3
-0.15
-0.13
Acquisitions
-4.5
Purchases of investments
-1.2
-1.2
Cash from investing
-4.4
-2.35
-1.91
-0.2
Debt repaid
-2.9
-2.05
Stock issued
0.04
0.5
0.03
0.22
8.4
3.72
Dividends paid
-1.17
Cash from financing
0.05
0.49
8.68
-4.83
2.31
-2.86
-2.05
-2.09
4.8
4.65
Exchange rate effect
0.02
-0.09
-0.12
0.05
Net change in cash
0.03
-0
3.64
-1.12
-0.52
-1.5
0.73
-1.79
0.06
1.93
Free cash flow
-0.65
5.74
-0.98
1.18
Interest paid
0
0.81
1.49
0.84
1.25
0.94
4.17
3.91
2.95
Income taxes paid
0.01
0.86
1.19
0.22
0.04
0.15
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $0.09 on September 17, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
308.3%
Gross profit / revenue.
Operating margin
-186.8%
Operating income / revenue.
EBITDA margin
-184.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-266.8%
Pre-tax income / revenue.
Net margin
-268.8%
Net income / revenue.
Operating cash flow margin
-64.8%
Cash from operations / revenue.
Return on assets (ROA)
-244.3%
Net income / average total assets.
Stock-based pay / revenue
4.3%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
2.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-12.8%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-14.1%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
-245.8%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-240.3%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-680.8%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-553.6%
EPS vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-37.8%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
27.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.93x
Current assets / current liabilities.
Quick ratio
0.23x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.04x
(Cash + short-term investments) / current liabilities.
Debt / assets
387.2%
Total debt / total assets.
Liabilities / assets
493.2%
Total liabilities / total assets.
Net debt
$24.7M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.40
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.52
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.34
Cash from operations / diluted weighted shares.
Book value per share
-$2.25
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.23x
Market cap / revenue.
EV/Sales
4.44x
Enterprise value / revenue.
Earnings yield
-1,171.0%
Net income / market cap (the inverse of P/E).
What was Synergy CHC Corp.'s revenue in fiscal 2025?
Synergy CHC Corp. reported revenue of $30.4M for fiscal 2025, 12.8% lower than the year before.
Was Synergy CHC Corp. profitable in fiscal 2025?
No. It reported a net loss of $12.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.